Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of golimumab on health-related quality of life, other patient-reported outcomes and healthcare resource utilization in patients with moderate-to-severe ulcerative colitis: a real-world multicenter, noninterventional, observational study in Greece.
Gatopoulou A, Christodoulou DK, Katsanos KH, Bakos D, Mouzas I, Tzouvala M, Theodoropoulou A, Paspatis G, Theocharis G, Thomopoulos K, Giouleme O, Kourikou A, Manolakopoulos S, Zampeli E, Michopoulos S, Karatzas P, Katsaros M, Moschovis D, Orfanoudaki E, Livieratos A, Petrikkou E, Mantzaris GJ. Gatopoulou A, et al. Among authors: orfanoudaki e. Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e615-e624. doi: 10.1097/MEG.0000000000002182. Eur J Gastroenterol Hepatol. 2021. PMID: 34034278
First case of Whipple's disease successfully treated with tigecycline.
Foteinogiannopoulou K, Mouzas I, Tzardi M, Orfanoudaki E, Theodoraki E, Kofteridis D. Foteinogiannopoulou K, et al. Among authors: orfanoudaki e. Germs. 2021 Mar 15;11(1):105-110. doi: 10.18683/germs.2021.1246. eCollection 2021 Mar. Germs. 2021. PMID: 33898347 Free PMC article.
Real-life utility and diagnostic accuracy of a home-performed fecal calprotectin test to predict endoscopic activity in patients with inflammatory bowel disease under maintenance treatment with adalimumab.
Orfanoudaki E, Drygiannakis I, Theodoraki E, Foteinogiannopoulou K, Mantaka A, Koutroubakis IE. Orfanoudaki E, et al. Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e777-e782. doi: 10.1097/MEG.0000000000002248. Eur J Gastroenterol Hepatol. 2021. PMID: 34284415
Implementation and Short-term Adverse Events of Anti-SARS-CoV-2 Vaccines in Inflammatory Bowel Disease Patients: An International Web-based Survey.
Ellul P, Revés J, Abreu B, Chaparro M, Gisbert JP, Allocca M, Fiorino G, Barberio B, Zingone F, Pisani A, Cassar D, Michalopoulos G, Mantzaris G, Koutroubakis I, Karmiris K, Katsanos K, Ďuricova D, Burisch J, Madsen GR, Maaser C, Naila A, Orfanoudaki E, Milivojevic V, Buisson A, Avedano L, Leone S, Torres J. Ellul P, et al. Among authors: orfanoudaki e. J Crohns Colitis. 2022 Aug 4;16(7):1070-1078. doi: 10.1093/ecco-jcc/jjac010. J Crohns Colitis. 2022. PMID: 35037033 Free PMC article.
Real-World Use and Adverse Events of SARS-CoV-2 Vaccination in Greek Patients with Inflammatory Bowel Disease.
Orfanoudaki E, Zacharopoulou E, Kitsou V, Karmiris K, Theodoropoulou A, Mantzaris GJ, Tzouvala M, Michopoulos S, Zampeli E, Michalopoulos G, Karatzas P, Viazis N, Liatsos C, Bamias G, Koutroubakis IE, On Behalf Of The Hellenic Group For The Study Of Ibd. Orfanoudaki E, et al. J Clin Med. 2022 Jan 27;11(3):641. doi: 10.3390/jcm11030641. J Clin Med. 2022. PMID: 35160092 Free PMC article.
Patients With Inflammatory Bowel Diseases Have Impaired Antibody Production After Anti-SARS-CoV-2 Vaccination: Results From a Panhellenic Registry.
Zacharopoulou E, Orfanoudaki E, Tzouvala M, Tribonias G, Kokkotis G, Kitsou V, Almpani F, Christidou A, Viazis N, Mantzaris GJ, Tsafaridou M, Karmiris K, Theodoropoulou A, Papathanasiou E, Zampeli E, Michopoulos S, Tigkas S, Michalopoulos G, Laoudi E, Karatzas P, Mylonas I, Kyriakos N, Liatsos C, Kafetzi T, Theocharis G, Taka S, Panagiotopoulou K, Koutroubakis IE, Bamias G. Zacharopoulou E, et al. Among authors: orfanoudaki e. Inflamm Bowel Dis. 2023 Feb 1;29(2):228-237. doi: 10.1093/ibd/izac068. Inflamm Bowel Dis. 2023. PMID: 35394529 Free PMC article.
The Effect of Early vs Delayed Initiation of Adalimumab on Remission Rates in Patients With Crohn's Disease With Poor Prognostic Factors: The MODIFY Study.
Mantzaris GJ, Zeglinas C, Theodoropoulou A, Koutroubakis I, Orfanoudaki E, Katsanos K, Christodoulou D, Michalopoulos G, Tzouvala M, Moschovis D, Michopoulos S, Zampeli E, Soufleris K, Ilias A, Chatzievangelinou C, Kyriakakis A, Antachopoulou K, Karmiris K. Mantzaris GJ, et al. Among authors: orfanoudaki e. Crohns Colitis 360. 2021 Sep 4;3(4):otab064. doi: 10.1093/crocol/otab064. eCollection 2021 Oct. Crohns Colitis 360. 2021. PMID: 36777275 Free PMC article.
31 results